½ÃÀ庸°í¼­
»óǰÄÚµå
1813267

¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀå ¿¹Ãø(-2032³â) : Á¦Ç°º°, ¾Ö¿Ïµ¿¹° À¯Çüº°, À¯Åë ä³Îº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®

DNA-Based Pet Nutrition Market Forecasts to 2032 - Global Analysis By Product (Genetic Testing Kits for Pets, Personalized Pet Meal Plans, and Nutraceutical Supplements), Pet Type, Distribution Channel, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀåÀº 2025³â¿¡ 4¾ï 5,328¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß 12.2%ÀÇ CAGR·Î ¼ºÀåÇϸç, 2032³â±îÁö 10¾ï 1,466¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

DNA ±â¹Ý ¹Ý·Áµ¿¹° ¿µ¾çÀº ¹Ý·Áµ¿¹°ÀÇ °íÀ¯ÇÑ DNA ±¸Á¶¸¦ Æò°¡Çϱâ À§ÇØ À¯ÀüÀÚ ºÐ¼®À» ¼öÇàÇÏ´Â ¸ÂÃãÇü ½Ä´Ü Àü·«ÀÔ´Ï´Ù. À¯ÀüÀû Ư¼º, ½ÄÀÌ ºÒ³»¼º, ´ë»ç ±â´É, °Ç°­ ¹Î°¨µµ¸¦ ÆÄ¾ÇÇÏ¿© Ưº°ÇÑ ¿µ¾ç °èȹÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ¼öÀÇ»ç¿Í º¸È£ÀÚ´Â Á¤È®ÇÑ ¿µ¾ç Áö¿øÀ» Á¦°øÇϰí, ´õ ³ªÀº ¼ÒÈ­¸¦ ÃËÁøÇϰí, Áúº´ À§ÇèÀ» ÁÙÀ̰í, ¹Ý·Áµ¿¹°ÀÇ Àü¹ÝÀûÀÎ °Ç°­, ¼ö¸í ¹× »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

¹Ý·Áµ¿¹°ÀÇ Àΰ£È­ ¹× ¸ÂÃã ¿µ¾ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

¹Ý·Áµ¿¹°ÀÌ Á¡Á¡ ´õ Áß¿äÇÑ °¡Á· ±¸¼º¿øÀ¸·Î ÀÚ¸® ÀâÀ¸¸é¼­ º¸È£ÀÚµéÀº °³º°ÀûÀÎ °ü¸®¸¦ ÅëÇØ ¹Ý·Áµ¿¹°ÀÇ °Ç°­°ú ÇູÀ» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­·Î ÀÎÇØ°³ ǰÁ¾º° ÇÊ¿ä¿Í À¯ÀüÀû ¼ÒÀο¡ ¸Â´Â DNA ±â¹Ý ¿µ¾ç °èȹ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀº ¾Ë·¹¸£±â, üÁß°ü¸®, ¸¸¼ºÁúȯ¿¡ ´ëÀÀÇÏ´Â ¸ÂÃãÇü ½Ä´ÜÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ÇÁ¸®¹Ì¾ö ¾Ö¿Ïµ¿¹° »ç·á ºê·£µå¿Í À£´Ï½º Ç÷§ÆûÀÇ µîÀåÀº ÀÌ·¯ÇÑ ÁøÈ­ÇÏ´Â »ç°í¹æ½ÄÀ» ¹Ý¿µÇÕ´Ï´Ù. µðÁöÅÐ Åø¿Í ¸ð¹ÙÀÏ ¾ÛÀº ¹Ý·Áµ¿¹° º¸È£ÀÚ¿¡°Ô ¸ÂÃãÇü ¿µ¾ç °ü¸®¸¦ ´õ¿í Ä£¼÷ÇÏ°í ¸Å·ÂÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î Àΰ£°ú ¹Ý·Áµ¿¹° »çÀÌÀÇ Á¤¼­Àû À¯´ë°¨ÀÌ °úÇÐÀû ±Ù°Å°¡ ÀÖ´Â ¸ÂÃãÇü ½Ä´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

DNA °Ë»ç ¹× ¸ÂÃãÇü ¿µ¾ç °èȹ¿¡ µå´Â °í°¡ÀÇ ºñ¿ë

¸¹Àº ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº À¯ÀüÀÚ Å°Æ®¿Í Áö¼ÓÀûÀÎ Á¤¾×Á¦ ¿µ¾ç ¼­ºñ½º¿¡ µå´Â Ãʱ⠺ñ¿ë¿¡ ´ëÇØ °í¹ÎÇϰí ÀÖ½À´Ï´Ù. º¸Çè Àû¿ë ¹üÀ§°¡ Á¦ÇÑÀûÀÌ°í »óȯ ¿É¼ÇÀÌ ¾ø½À´Ï´Ù´Â Á¡ÀÌ ½ÃÀå ħÅõ¸¦ ´õ¿í Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ±¹°¡¿¡¼­´Â °æÁ¦ÀûÀÎ ¹®Á¦°¡ ´õ µÎµå·¯Á® º¸±ÞÀÌ ´Ê¾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼öÀÇ»ç ÁøÂûÀÇ Çʿ伺ÀÌ ÃÑ ºñ¿ë¿¡ Ãß°¡µÇ¹Ç·Î ¿¹»êÀ» Áß½ÃÇÏ´Â ¼ÒºñÀÚ¿¡°Ô´Â ½ÇÇà °¡´É¼ºÀÌ ³·½À´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû Á¦¾àÀº È®À强À» ÀúÇØÇÏ°í °í±Þ ¿µ¾ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Á¦ÇÑÇÕ´Ï´Ù.

°í±Þ ¿µ¾çÇÐÀû ÀλçÀÌÆ®¸¦ À§ÇÑ AI¿Í ºòµ¥ÀÌÅÍÀÇ ÅëÇÕ

AI¿Í µ¥ÀÌÅÍ ºÐ¼®ÀÇ ±â¼ú ¹ßÀüÀº ¹Ý·Áµ¿¹°ÀÇ ¿µ¾çÇп¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¾Ë°í¸®ÁòÀº ÇöÀç À¯ÀüÀÚ ¸¶Ä¿, ¶óÀÌÇÁ½ºÅ¸ÀÏ ÀÔ·Â, °Ç°­ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© Ãʰ³ÀÎÈ­µÈ ½Ä´Ü °èȹÀ» »ý¼º ÇÒ ¼ö ÀÖ½À´Ï´Ù. °¢ Ç÷§ÆûÀº ¸Ó½Å·¯´×À» Ȱ¿ëÇÏ¿© ¹Ý·Áµ¿¹°ÀÇ Çൿ°ú Çǵå¹é ·çÇÁ¸¦ ±â¹ÝÀ¸·Î Áö¼ÓÀûÀ¸·Î ÃßõÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â ¹× ½º¸¶Æ® ÇÇ´õ¿ÍÀÇ ÅëÇÕÀ» ÅëÇØ ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ÀûÀÀÇü ¿µ¾ç ¼·Ãë°¡ °¡´ÉÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀ» ÅëÇØ ¿øÈ°ÇÑ ¾÷µ¥ÀÌÆ®¿Í ¼öÀÇ»ç Àü¹®°¡¿ÍÀÇ ¿ø°Ý »ó´ãÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀ» ÅëÇØ ¹Ý·Áµ¿¹°ÀÇ °Ç°­ °á°ú¿Í »ç¿ëÀÚ °æÇèÀ» Çâ»ó½ÃŰ´Â È®Àå °¡´ÉÇÑ µ¥ÀÌÅͺ£À̽º ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

ºÎÁ¤È®Çϰųª ¿ÀÇØÀÇ ¼ÒÁö°¡ ÀÖ´Â À¯ÀüÀÚ °Ë»ç °á°úÀÇ À§Ç輺

¹Ý·Áµ¿¹° DNA °Ë»çÀÇ ½Å·Ú¼ºÀº °Ë»ç±â°ü¿¡ µû¶ó Å©°Ô Â÷À̰¡ ³ª±â ¶§¹®¿¡ µ¥ÀÌÅÍÀÇ Á¤È®¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ ³º°í ÀÖ½À´Ï´Ù. À¯ÀüÀÚ °Ë»ç °á°ú¸¦ À߸ø ÇØ¼®ÇÏ¸é ºÎÀûÀýÇÑ ½Ä´Ü ¼±Åðú °Ç°­ À§ÇèÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. Ç¥ÁØÈ­µÈ °Ë»ç ÇÁ·ÎÅäÄݰú ±ÔÁ¦ °¨µ¶ÀÇ ºÎÀç°¡ ÀÌ ¹®Á¦¸¦ ´õ¿í ¾ÇÈ­½Ã۰í ÀÖ½À´Ï´Ù. ÃæºÐÇÑ °úÇÐÀû °ËÁõ ¾øÀÌ °á°ú¸¦ °úµµÇÏ°Ô ¾à¼ÓÇÏ´Â Ç÷§Æûµµ ÀÖÀ¸¸ç, ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ¶³¾î¶ß¸³´Ï´Ù. ǰÁ¾ ½Äº°À̳ª °Ç°­ ¼ÒÀÎÀÇ ¿À·ù´Â À߸øµÈ °³ÀÔÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À§ÇùÀº DNA ±â¹Ý ¿µ¾ç ¼­ºñ½º¿¡¼­ ¾ö°ÝÇÑ °ËÁõ, Åõ¸í¼º, Àü¹®°¡ ÁöµµÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

ÆÒµ¥¹ÍÀº ¹Ý·Áµ¿¹° ¾çÀ°À» °¡¼ÓÈ­Çϰí, Á¤¼­Àû À¯´ë°¨À» °­È­Çϸç, ¹Ý·Áµ¿¹°ÀÇ °Ç°­¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇß½À´Ï´Ù. ·Ï´Ù¿îÀ¸·Î ÀÎÇØ °³ÀÎÈ­µÈ ¹Ý·Áµ¿¹° »ç·á¿Í DNA ŰƮÀÇ ¿Â¶óÀÎ ±¸¸Å°¡ Áõ°¡Çß½À´Ï´Ù. °ø±Þ¸ÁÀÇ È¥¶õÀ¸·Î ÀÎÇØ ÀϽÃÀûÀ¸·Î Á¦Ç° Àç°í »óȲ°ú ³³±â¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿ø°Ý ÄÁ¼³ÆÃ°ú Á¤±â ±¸¸ÅÇü ¿µ¾ç ¼­ºñ½º¸¦ Á¦°øÇÏ´Â µðÁöÅÐ Ç÷§ÆûÀÌ È®»êµÇ°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ È¸º¹·Â ÀÖ°í ¹Ì·¡ÁöÇâÀûÀÎ ÄÉ¾î ¸ðµ¨À» Ãß±¸ÇÏ´Â °¡¿îµ¥, DNA ±â¹Ý ¿µ¾çÀº ÆÒµ¥¹Í ÀÌÈÄ ¹Ý·Áµ¿¹° °Ç°­ÀÇ Áß¿äÇÑ ÃàÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ Áß °³º°È­µÈ ¹Ý·Áµ¿¹° ½Ä»ç °èȹ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°³º°È­µÈ ¹Ý·Áµ¿¹° ½Ä»ç °èȹ ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº ¾Ë·¹¸£±â, ¼ÒÈ­±â Áúȯ, üÁß °ü¸® µî¿¡ ´ëÀÀÇÏ´Â ¸ÂÃãÇü »ç·á¸¦ ¼±ÅÃÇÏ´Â °æÇâÀÌ °­ÇØÁö°í ÀÖ½À´Ï´Ù. ±¸µ¶ ¸ðµ¨°ú ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å Ç÷§ÆûÀº ¸ÂÃãÇü ¿µ¾ç¿¡ ´ëÇÑ Á¢±ÙÀ» ´Ü¼øÈ­Çϰí ÀÖ½À´Ï´Ù. ¿ø·á Á¶´Þ°ú ¹èÇÕÀÇ ¹ßÀüÀ¸·Î Á¦Ç°ÀÇ Ç°Áú°ú È¿´ÉÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. À¯ÀüÀû ÀλçÀÌÆ®¸¦ ½Ä´Ü °èȹ¿¡ ÅëÇÕÇÏ´Â °ÍÀº Ç¥ÁØ ±â´ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. °³ÀÎÈ­°¡ ÁÖ·ù·Î ÀÚ¸® ÀâÀ¸¸é¼­ ÀÌ ºÎ¹®Àº DNA ±â¹Ý ¹Ý·Áµ¿¹° ¿µ¾çÁ¦ ½ÃÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¹Ý·Áµ¿¹° À£´Ï½º ½ºÅ¸Æ®¾÷ ¹× Ç÷§Æû ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿¹Ãø ±â°£ Áß ¹Ý·Áµ¿¹° À£´Ï½º ½ºÅ¸Æ®¾÷ ¹× Ç÷§Æû ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Çõ½Å¿¡´Â ¸ð¹ÙÀÏ ¾Û, AI¸¦ Ȱ¿ëÇÑ Áø´Ü, ±¸µ¶Çü DNA °Ë»ç ŰƮ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¹Îø¼ºÀº ¼ÒºñÀÚÀÇ ÃëÇâ°ú »õ·Î¿î µ¿Çâ¿¡ ºü¸£°Ô ÀûÀÀÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. µ¿¹°º´¿ø ³×Æ®¿öÅ© ¹× E-Commerce Ç÷§Æû°úÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ µµ´Þ ¹üÀ§¸¦ ³ÐÇô°¡°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ÀüÀÎÀû Ä¡·á¿Í ¿¹¹æ ÀǷḦ ¹Þ¾ÆµéÀ̸鼭 À̵é Ç÷§ÆûÀº ºñ¾àÀûÀÎ ¼ºÀåÀ» Çϰí ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À² Áö¿ª

¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹Ý·Áµ¿¹° »çÀ° Áõ°¡¿Í µµ½ÃÈ­·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÇÁ¸®¹Ì¾ö ¸ÂÃãÇü ¿µ¾ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. E-CommerceÀÇ ¼ºÀå°ú ¸ð¹ÙÀÏ ¿ì¼±ÀÇ ¼ÒºñÀÚ ÇൿÀº µðÁöÅÐ À£´Ï½º Ç÷§ÆûÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. Áö¿ª ±â¾÷Àº Áö¿ª Ưȭ Á¦Á¦ ¹× ǰÁ¾º° ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. µ¿¹° º¹Áö¿Í ¼öÀÇÇÐ ÀÎÇÁ¶ó¸¦ ÃËÁøÇÏ´Â Á¤ºÎÀÇ ±¸»óÀÌ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¿¹Ãø ±â°£ Áß ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, °í±Þ ¼öÀÇÇÐ ¼­ºñ½º ¹× ±â¼ú¿¡ Á¤ÅëÇÑ ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚÀÇ ÁöÁö¸¦ ¹ÞÀ» °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯ÀüÀÚ °Ë»ç¿Í ¸ÂÃãÇü ¿µ¾ç Ç÷§ÆûÀÇ ³ôÀº º¸±Þ·üÀº ºü¸¥ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á, ½º¸¶Æ® ÇÇ´õ, AI ±â¹Ý Áø´Ü µîÀÇ µ¿ÇâÀÌ ¾Ö¿Ïµ¿¹° ÄɾîÀÇ ±Ô¹üÀ» À籸¼ºÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦°¡ ¸íÈ®ÇØÁö°í °úÇÐÀû ±Ù°Å°¡ ÀÖ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ½Å·Ú°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå ½Å·Úµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß°ú Á¦Ç° Çõ½Å¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ°¡ °æÀïÀû Â÷º°È­¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷¼Ò°³
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3»ç)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¿ªÀû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç ¾îÇÁ·ÎÄ¡
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç ÀÚ·á
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀå : Á¦Ç°º°

  • ¾Ö¿Ïµ¿¹°¿ë À¯ÀüÀÚ °Ë»ç ŰƮ
    • ǰÁ¾ ƯÀÌÀû DNA ÆÐ³Î
    • ¿µ¾ç °Ô³ð ÇÁ·ÎÆÄÀϸµ
    • °Ç°­ ¸®½ºÅ© ½ºÅ©¸®´×
  • ¸ÂÃãÇü ¾Ö¿Ïµ¿¹°¿ë ½Ä»ç Ç÷£
    • ¿¬·É°ú À¯Çüº° ¸ÂÃãÇü ½Ä»ç
    • ¿¹¹æÀû °Ç°­ ´ÙÀÌ¾îÆ®
    • ¾Ë·¹¸£±â¿Í °ú¹ÎÁõ¿¡ ±â¹ÝÇÑ Ã³¹æ
  • ¿µ¾çº¸ÃæÁ¦
    • °üÀý°ú °¡µ¿¼º Áö¿ø
    • ÇÇºÎ¿Í ÇǸ𸦠À§ÇÑ Æ÷¹Ä·¯
    • ¼ÒÈ­±â°è °Ç°­ ÁõÁøÁ¦
    • ¸é¿ª·Â Çâ»óÁ¦

Á¦6Àå ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀå : ¾Ö¿Ïµ¿¹° À¯Çüº°

  • °³
  • °í¾çÀÌ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀå : À¯Åë ä³Îº°

  • ¼ÒºñÀÚ Á÷ÆÇ(DTC) Ç÷§Æû
  • ¿Â¶óÀÎ ¼­ºê½ºÅ©¸³¼Ç ¸ðµ¨
  • ¼öÀÇ Å¬¸®´Ð
  • ¾Ö¿Ïµ¿¹° Àü¹® ¼Ò¸ÅÁ¡

Á¦8Àå ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀå : ¿ëµµº°

  • ¿¹¹æÀû ÇコÄɾî
  • Çൿ°ú ÀÎÁö °Ç°­
  • ¸¸¼ºÁúȯ Áö¿ø
  • üÁß°ú ´ë»ç ÃÖÀûÈ­
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¾Ö¿Ïµ¿¹° ¼ÒÀ¯ÁÖ
  • ¼öÀÇ Àü¹®°¡
  • ¾Ö¿Ïµ¿¹° À£´Ï½º ½Å±Ô ±â¾÷¡¤Ç÷§Æû
  • ±âŸ

Á¦10Àå ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, Á¶ÀÎÆ® º¥Ã³
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Mars, Inc.
  • ADM
  • Nestle S.A.
  • Boehringer Ingelheim Animal Health
  • Colgate-Palmolive Company
  • Chr. Hansen Holding A/S
  • The J.M. Smucker Company
  • BASF SE
  • General Mills, Inc.
  • IDEXX Laboratories, Inc.
  • Freshpet, Inc.
  • DSM-Firmenich AG
  • Zoetis Inc.
  • Virbac S.A.
  • Elanco Animal Health Incorporated
KSA 25.09.30

According to Stratistics MRC, the Global DNA-Based Pet Nutrition Market is accounted for $453.28 million in 2025 and is expected to reach $1014.66 million by 2032 growing at a CAGR of 12.2% during the forecast period. DNA-based pet nutrition is a customized dietary strategy that relies on genetic analysis to evaluate a pet's unique DNA structure. Through the identification of genetic traits, dietary intolerances, metabolic functions, and health susceptibilities, it enables the development of specialized nutrition plans. This approach allows veterinarians and pet owners to deliver accurate nutritional support, promoting better digestion, reducing disease risks, and improving pets' overall health, longevity, and quality of life.

Market Dynamics:

Driver:

Growing pet humanization and demand for personalized nutrition

As pets increasingly become integral family members, owners are prioritizing their health and well-being through personalized care. This shift has led to growing interest in DNA-based nutrition plans that cater to breed-specific needs and genetic predispositions. Consumers are seeking customized diets that address allergies, weight management, and chronic conditions. The rise of premium pet food brands and wellness platforms reflects this evolving mindset. Digital tools and mobile apps are making personalized nutrition more accessible and engaging for pet owners. Overall, the emotional bond between humans and pets is fueling demand for scientifically backed, individualized meal solutions.

Restraint:

High cost of DNA testing and customized nutrition plans

Many pet owners are deterred by the upfront costs of genetic kits and ongoing subscription-based nutrition services. Limited insurance coverage and lack of reimbursement options further restrict market penetration. In emerging economies, affordability challenges are more pronounced, slowing uptake. Additionally, the need for veterinary consultation adds to the total cost, making it less viable for budget-conscious consumers. These financial constraints hinder scalability and limit access to advanced nutritional solutions.

Opportunity:

Integration of AI and big data for advanced nutrition insights

Technological advancements in AI and data analytics are revolutionizing the pet nutrition landscape. Algorithms can now analyze genetic markers, lifestyle inputs, and health data to generate hyper-personalized diet plans. Platforms are leveraging machine learning to continuously refine recommendations based on pet behavior and feedback loops. Integration with wearable devices and smart feeders enables real-time monitoring and adaptive nutrition. Cloud-based systems allow seamless updates and remote consultations with veterinary experts. These innovations are unlocking scalable, data-driven solutions that enhance pet health outcomes and user experience.

Threat:

Risk of inaccurate or misleading genetic test results

The reliability of pet DNA tests varies widely across providers, raising concerns about data accuracy. Misinterpretation of genetic results can lead to inappropriate dietary choices and health risks. Lack of standardized testing protocols and regulatory oversight exacerbates the issue. Some platforms overpromise outcomes without sufficient scientific validation, eroding consumer trust. Errors in breed identification or health predisposition can result in misguided interventions. This threat underscores the need for rigorous validation, transparency, and professional guidance in DNA-based nutrition services.

Covid-19 Impact

The pandemic accelerated pet adoption and deepened emotional bonds, prompting greater investment in pet wellness. Lockdowns led to increased online purchases of personalized pet food and DNA kits. Supply chain disruptions temporarily affected product availability and delivery timelines. Digital platforms offering remote consultations and subscription-based nutrition gained traction. As pet owners seek resilient and proactive care models, DNA-based nutrition is emerging as a key pillar of post-pandemic pet wellness.

The personalized pet meal plans segment is expected to be the largest during the forecast period

The personalized pet meal plans segment is expected to account for the largest market share during the forecast period, driven by rising demand for breed-specific and condition-targeted diets. Owners are increasingly opting for tailored meals that address allergies, digestive issues, and weight management. Subscription models and direct-to-consumer platforms are simplifying access to customized nutrition. Advancements in ingredient sourcing and formulation are enhancing product quality and efficacy. Integration of genetic insights into meal planning is becoming a standard feature. As personalization becomes mainstream, this segment is set to anchor the DNA-based pet nutrition market.

The pet wellness start-ups & platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pet wellness start-ups & platforms segment is predicted to witness the highest growth rate, as these players are disrupting traditional pet care with tech-enabled solutions and data-driven nutrition. Innovations include mobile apps, AI-powered diagnostics, and subscription-based DNA testing kits. Their agility allows rapid adaptation to consumer preferences and emerging trends. Strategic partnerships with veterinary networks and e-commerce platforms are expanding reach. As pet owners embrace holistic and preventive care, these platforms are poised for exponential growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share fuelled by rising pet ownership and urbanization. Increasing disposable income and awareness of pet health are driving demand for premium and personalized nutrition. E-commerce growth and mobile-first consumer behavior are accelerating adoption of digital wellness platforms. Regional players are investing in localized formulations and breed-specific solutions. Government initiatives promoting animal welfare and veterinary infrastructure are supporting market expansion.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, supported by advanced veterinary services and tech-savvy pet owners. High penetration of genetic testing and personalized nutrition platforms is driving rapid adoption. Trends like telehealth, smart feeders, and AI-driven diagnostics are reshaping pet care norms. Regulatory clarity and consumer trust in science-backed products are boosting market confidence. Strategic investments in R&D and product innovation are fueling competitive differentiation.

Key players in the market

Some of the key players profiled in the DNA-Based Pet Nutrition Market include Mars, Inc., ADM, Nestle S.A., Boehringer Ingelheim Animal Health, Colgate-Palmolive Company, Chr. Hansen Holding A/S, The J.M. Smucker Company, BASF SE, General Mills, Inc., IDEXX Laboratories, Inc., Freshpet, Inc., DSM-Firmenich AG, Zoetis Inc., Virbac S.A., and Elanco Animal Health Incorporated.

Key Developments:

In June 2025, ADM and PYCO Industries, Inc., announced that they have signed an agreement to launch a joint venture combining their Lubbock, Texas, cottonseed processing capabilities. The new joint venture will be majority-owned by PYCO and governed by a 6-member board with equal representation from ADM and PYCO. ADM and PYCO will each contribute their Lubbock-based processing facilities to the new company.

In August 2024, Mars, Incorporated, and Kellanova announced that they have entered into a definitive agreement under which Mars has agreed to acquire Kellanova for $83.50 per share in cash, for a total consideration of $35.9 billion, including assumed net leverage.1

Products Covered:

  • Genetic Testing Kits for Pets
  • Personalized Pet Meal Plans
  • Nutraceutical Supplements

Pet Types Covered:

  • Dogs
  • Cats
  • Other Companion Animals

Distribution Channels Covered:

  • Direct-to-Consumer (DTC) Platforms
  • Online Subscription Models
  • Veterinary Clinics
  • Specialty Pet Retailers

Applications Covered:

  • Preventive Health Management
  • Behavioral & Cognitive Health
  • Chronic Condition Support
  • Weight & Metabolism Optimization
  • Other Applications

End Users Covered:

  • Pet Owners
  • Veterinary Professionals
  • Pet Wellness Startups & Platforms
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global DNA-Based Pet Nutrition Market, By Product

  • 5.1 Introduction
  • 5.2 Genetic Testing Kits for Pets
    • 5.2.1 Breed-specific DNA Panels
    • 5.2.2 Nutrigenomic Profiling
    • 5.2.3 Health Risk Screening
  • 5.3 Personalized Pet Meal Plans
    • 5.3.1 Age- and Breed-tailored Diets
    • 5.3.2 Preventive Health Diets
    • 5.3.3 Allergy and Sensitivity-Based Formulations
  • 5.4 Nutraceutical Supplements
    • 5.4.1 Joint & Mobility Support
    • 5.4.2 Skin & Coat Formulas
    • 5.4.3 Digestive Health Enhancers
    • 5.4.4 Immune Boosters

6 Global DNA-Based Pet Nutrition Market, By Pet Type

  • 6.1 Introduction
  • 6.2 Dogs
  • 6.3 Cats
  • 6.4 Other Companion Animals

7 Global DNA-Based Pet Nutrition Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct-to-Consumer (DTC) Platforms
  • 7.3 Online Subscription Models
  • 7.4 Veterinary Clinics
  • 7.5 Specialty Pet Retailers

8 Global DNA-Based Pet Nutrition Market, By Application

  • 8.1 Introduction
  • 8.2 Preventive Health Management
  • 8.3 Behavioral & Cognitive Health
  • 8.4 Chronic Condition Support
  • 8.5 Weight & Metabolism Optimization
  • 8.6 Other Applications

9 Global DNA-Based Pet Nutrition Market, By End User

  • 9.1 Introduction
  • 9.2 Pet Owners
  • 9.3 Veterinary Professionals
  • 9.4 Pet Wellness Startups & Platforms
  • 9.5 Other End Users

10 Global DNA-Based Pet Nutrition Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Mars, Inc.
  • 12.2 ADM
  • 12.3 Nestle S.A.
  • 12.4 Boehringer Ingelheim Animal Health
  • 12.5 Colgate-Palmolive Company
  • 12.6 Chr. Hansen Holding A/S
  • 12.7 The J.M. Smucker Company
  • 12.8 BASF SE
  • 12.9 General Mills, Inc.
  • 12.10 IDEXX Laboratories, Inc.
  • 12.11 Freshpet, Inc.
  • 12.12 DSM-Firmenich AG
  • 12.13 Zoetis Inc.
  • 12.14 Virbac S.A.
  • 12.15 Elanco Animal Health Incorporated
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦